📰 Advanced Prostate News
Page 2 - Advanced Prostate News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Advanced Prostate. Real-time updates on events, politics, business and more.
October 26, 2022
/PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the Class of 2022 Young Investigator Award recipients totaling $7.2 million in funding for...
August 16, 2022
Investegate announcements from AstraZeneca PLC, Lynparza granted FDA priority review for PROpel
August 3, 2022
/PRNewswire/ -- The "Cancer Therapies - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.coms offering. Global Cancer...
August 3, 2022
/PRNewswire/ -- The "Cancer Therapies - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.coms offering. Global Cancer...
June 21, 2022
Results from the PROpel Phase III trial showed that AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone significantly improved radiographic progression-free survival (rPFS) versus abiraterone alone as a 1st-line treatment for patients with metastatic castration-resistant prostate cancer ...
March 24, 2022
FDA also approved complementary diagnostic imaging agent, Locametz®, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions2...
March 23, 2022
Ad hoc announcement pursuant to Art. 53 LR FDA also approved complementary diagnostic imaging agent, Locametz®, after radiolabeling with gallium-68...
March 23, 2022
Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis PluvictoTM approved by FDA as first targeted radioligand therapy for treatment of progressive, PSMA positive metastatic castration-resistant prostate cancer
March 23, 2022
Ad hoc announcement pursuant to Art. 53 LR FDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions2 Metastatic
February 24, 2022
/PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the 2021 Class of PCF Team Challenge Award recipients and a total of more than $9 million...